Lupin Pharmaceuticals Inc, a subsidiary of Lupin, has agreed to end the marketing agreement with Chester Valley Pharmaceuticals to promote Atopiclair, a non-steroidal cream, to pediatricians in the United States.According to a release issued by Lupin to the BSE today, the deal was signed in March 2006, and "both the parties have now mutually agreed to end the agreement and independently pursue their respective business plans."
